The Reduction of PSMB4 in T24 and J82 Bladder Cancer Cells Inhibits the Angiogenesis and Migration of Endothelial Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25105559 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yi-Hsuan Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Anatomy, National Defense Medical Center, Taipei 11490, Taiwan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cell Movement, Neovascularization, Pathologic, Proteasome Endopeptidase Complex. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Ministry of National Defense-Medical Affairs Bureau, Cheng Hsin General Hospital.
Abstract (Originalsprache)
Bladder cancer (BC) is a malignant tumor of the urinary system with high mortality and recurrence rates. Proteasome subunit type 4 (PSMB4) is highly expressed and has been identified as having oncogenic properties in a variety of cancer types. This study aimed to explore the effect of PSMB4 knockdown on the survival, migration, and angiogenesis of human bladder cancer cells with different degrees of malignancy. We analyzed the effects of PSMB4 knockdown in bladder cancer cells and endothelial cells in the tumor microenvironment. PSMB4 was highly expressed in patients with low- and high-grade urothelial carcinoma. Inhibition of PSMB4 reduced protein expression of focal adhesion kinase (FAK) and myosin light chain (MLC), leading to reduced migration. Furthermore, the suppression of PSMB4 decreased the levels of vascular endothelial factor B (VEGF-B), resulting in lower angiogenic abilities in human bladder cancer cells. PSMB4 inhibition affected the migratory ability of HUVECs and reduced VEGFR2 expression, consequently downregulating angiogenesis. In the metastatic animal model, PSMB4 knockdown reduced the relative volumes of lung tumors. Our findings suggest the role of PSMB4 as a potential target for therapeutic strategies against human bladder cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology and Anatomy, National Defense Medical Center, Taipei 11490, Taiwan.
- Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan.
- Department of Urology, Cheng Hsin General Hospital, Taipei 11490, Taiwan.
- Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan.
ORCID-Profile: Yu-Ling Tsai, Wen-Chiuan Tsai, Ying Chen
Förderung
- National Science and Technology Council
- Ministry of National Defense-Medical Affairs Bureau
- Cheng Hsin General Hospital
Zitieren
APA
Lin, Y. H., Chen, T. M., Tsai, Y. L., Tsai, W. C., Wang, H. H., Chen, Y., & Wu, S. T. (2024). The Reduction of PSMB4 in T24 and J82 Bladder Cancer Cells Inhibits the Angiogenesis and Migration of Endothelial Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105559
Vancouver
Lin YH, Chen TM, Tsai YL, Tsai WC, Wang HH, Chen Y, et al. The Reduction of PSMB4 in T24 and J82 Bladder Cancer Cells Inhibits the Angiogenesis and Migration of Endothelial Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105559
BibTeX
@article{Lin2024,
author = {Lin, Yi-Hsuan and Chen, Tzu-Min and Tsai, Yu-Ling and Tsai, Wen-Chiuan and Wang, Hisao-Hsien and Chen, Ying and Wu, Sheng-Tang},
title = {The Reduction of PSMB4 in T24 and J82 Bladder Cancer Cells Inhibits the Angiogenesis and Migration of Endothelial Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25105559}
}
EUVIMED